Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02482233 · ClinicalTrials.gov registry record · Phase 4
The END Perioperative Smoking Pilot Study
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT02482233 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants.
The verdict
NCT02482233, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this pilot randomized trial is to determine the feasibility of e-cigarettes and telephone counselling (compared to transdermal nicotine replacement and telephone counselling) as a harm-reduction tool that may lead to increased smoking cessation in the perioperative setting in smokers presenting for elective surgery at the San Francisco Veterans Affairs Medical Center. Secondary outcomes include acceptability of e-cigarettes over transdermal nicotine replacement, length-of-stay in the post-anesthesia care unit, hospital length-of-stay, postoperative complications within the first 30-days, and smoking status 8-weeks after randomization. This pilot study is designed to provide the preliminary data necessary to plan and fund a larger-scale randomized clinical trial that will assess the utility of e-cigarettes in achieving smoking cessation perioperatively. Our ultimate goal is to add to the limited existing data on the safety and efficacy of e-cigarette use in smoking cessation, specifically in the perioperative setting where the risks of continued smoking are great and the motivation to stop is high.
Interventions
- BEHAVIORAL telephone counseling
- BEHAVIORAL ENDD (NJOY)
- DRUG NRT (NicoDerm CQ)
- BEHAVIORAL brief advice
- BEHAVIORAL brochure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02482233
The ClinicalTrials.gov registry entry for NCT02482233 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which telephone counseling is the first listed.
NCT02482233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02482233 about?
NCT02482233 is a clinical study titled "The END Perioperative Smoking Pilot Study". The purpose of this pilot randomized trial is to determine the feasibility of e-cigarettes and telephone counselling (compared to transdermal nicotine replacement and telephone counselling) as a harm-reduction tool that may lead to increased smoking cessation in the perioperative setting in smokers ...
What is the current status of trial NCT02482233?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2015-08. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02482233?
The interventions under investigation include: telephone counseling (BEHAVIORAL), ENDD (NJOY) (BEHAVIORAL), NRT (NicoDerm CQ) (DRUG), brief advice (BEHAVIORAL), brochure (BEHAVIORAL).
Who is sponsoring clinical trial NCT02482233?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.